Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report

被引：11

作者：

Bay, J. -O. ^{[1
]}

de latour, R. Peffault ^{[2
]}

Bruno, B. ^{[3
]}

Coiteux, V. ^{[4
]}

Guillaume, T. ^{[5
]}

Hicheri, Y. ^{[6
]}

Paillard, C. ^{[7
]}

Suarez, F. ^{[8
]}

Turlure, P. ^{[9
]}

Alain, S. ^{[10
]}

Bulabois, C. -E. ^{[11
]}

Socie, G. ^{[2
]}

Bauters, F. ^{[4
]}

Yakoub-Agha, I. ^{[4
]}

机构：

[1] CHU Estaing, Serv Therapie Cellulaire & Hematol Clin, F-63003 Clermont Ferrand 1, France

[2] Hop St Louis, Serv Hematol Greffe Moelle, F-75475 Paris, France

[3] CHRU Lille, Hop Jeanne Flandres, Serv Hematol Pediat, F-59037 Lille, France

[4] CHRU Lille, EA 2686, Serv Malad Sang, F-59037 Lille, France

[5] CHU Nantes, Hotel Dieu, Serv Hematol Clin, F-44093 Nantes 1, France

[6] CHU Montpellier, Serv Hematol, F-34295 Montpellier, France

[7] CHRU Strasbourg, Hop Hautepierre, Serv Hematol & Oncol Pediat, F-67098 Strasbourg, France

[8] Hop Necker Enfants Malad, Serv Hematol Adultes, F-75015 Paris, France

[9] CHU Limoges, Hop Dupuytren, Serv Hematol, F-87042 Limoges, France

[10] CHU Limoges, Hop Dupuytren, Virol Lab, F-87042 Limoges, France

[11] CHU Grenoble, Hop Albert Michallon, Serv Hematol, F-38043 Grenoble 9, France

来源：

PATHOLOGIE BIOLOGIE | 2013年 / 61卷 / 04期

关键词：

Allogeneic stem cell transplantation; CMV; EBV; CYTOMEGALOVIRUS; RECIPIENTS;

D O I：

10.1016/j.patbio.2013.07.003

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the third annual series of workshops which brought together practitioners from all member centers and took place in October 2012 in Lille. Here the SFGM-TC addressed the issue of post-transplant CMV and EBV reactivation, and EBV-related Lymphoproliferative Disorders. (C) 2013 Published by Elsevier Masson SAS.

引用

页码：152 / 154

页数：3

共 4 条

[1] How I treat cytomegalovirus in hematopoietic cell transplant recipients [J].

Boeckh, Michael ;

Ljungman, Per .

BLOOD, 2009, 113 (23) :5711-5719

[2] How I treat EBV lymphoproliferation [J].

Heslop, Helen E. .

BLOOD, 2009, 114 (19) :4002-4008

[3] Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients [J].

Pietersma, Floor L. ;

van Dorp, Suzanne ;

Minnema, Monique C. ;

Kuball, Jurgen ;

Meijer, Ellen ;

Schuurman, Rob ;

van Baarle, Debbie .

CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) :E144-E148

[4] Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation [J].

Thiele, Thomas ;

Krueger, William ;

Zimmermann, Kathrin ;

Ittermann, Till ;

Wessel, Antje ;

Steinmetz, Ivo ;

Doelken, Gottfried ;

Greinacher, Andreas .

TRANSFUSION, 2011, 51 (12) :2620-2626

← 1 →